XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Consolidated Entity Excluding Consolidated Funds
Common Stock
Consolidated Entity Excluding Consolidated Funds
Additional paid-in capital
Consolidated Entity Excluding Consolidated Funds
Retained earnings (deficit)
Consolidated Entity Excluding Consolidated Funds
Accumulated other comprehensive income (loss)
Consolidated Entity Excluding Consolidated Funds
Total stockholders’ equity
Consolidated Entity Excluding Consolidated Funds
Non- controlling interests
Consolidated Funds
Non- controlling interests
Beginning balance (in shares) at Dec. 31, 2020   79.4            
Beginning balance at Dec. 31, 2020 $ 384.4 $ 0.1 $ 492.4 $ (176.5) $ (13.6) $ 302.4 $ 1.7 $ 80.3
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)   0.4            
Issuance of common stock 0.2   0.2     0.2    
Capital contributions 33.5           3.8 29.7
Equity-based compensation 1.3   1.3     1.3    
Foreign currency translation adjustment 0.3       0.3 0.3    
Amortization related to derivatives securities, net of tax 1.8       1.8 1.8    
Withholding tax related to stock option exercise (8.9)   (8.9)     (8.9)    
Other changes in non-controlling interests (5.5)           (5.5)  
Net de-consolidation of Funds (178.0)             (178.0)
Dividends (2.3)     (2.3)   (2.3)    
Net income 857.2     789.2   789.2   68.0
Ending balance (in shares) at Sep. 30, 2021   79.8            
Ending balance at Sep. 30, 2021 1,084.0 $ 0.1 485.0 610.4 (11.5) 1,084.0 0.0 0.0
Beginning balance (in shares) at Jun. 30, 2021   79.4            
Beginning balance at Jun. 30, 2021 863.9 $ 0.1 493.4 381.6 (11.2) 863.9 0.0 0.0
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)   0.4            
Issuance of common stock 0.1   0.1     0.1    
Equity-based compensation 0.4   0.4     0.4    
Foreign currency translation adjustment (0.9)       (0.9) (0.9)    
Amortization related to derivatives securities, net of tax 0.6       0.6 0.6    
Withholding tax related to stock option exercise (8.9)   (8.9)     (8.9)    
Dividends (0.7)     (0.7)   (0.7)    
Net income 229.5     229.5   229.5   0.0
Ending balance (in shares) at Sep. 30, 2021   79.8            
Ending balance at Sep. 30, 2021 1,084.0 $ 0.1 485.0 610.4 (11.5) 1,084.0 0.0 0.0
Beginning balance (in shares) at Dec. 31, 2021   45.4            
Beginning balance at Dec. 31, 2021 (17.6) $ 0.0 0.0 (6.8) (10.8) (17.6) 0.0 0.0
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)   0.2            
Repurchase of common stock (in shares)   (4.2)            
Repurchase of common stock (103.2)     (103.2)   (103.2)    
Equity-based compensation 1.8   1.8     1.8    
Foreign currency translation adjustment (5.6)       (5.6) (5.6)    
Amortization related to derivatives securities, net of tax 2.8       2.8 2.8    
Withholding tax related to stock option exercise (2.3)   (0.9) (1.4)   (2.3)    
Dividends (1.2)     (1.2)   (1.2)    
Net income 70.2     70.2   70.2    
Ending balance (in shares) at Sep. 30, 2022   41.4            
Ending balance at Sep. 30, 2022 (55.1) $ 0.0 0.9 (42.4) (13.6) (55.1) 0.0 0.0
Beginning balance (in shares) at Jun. 30, 2022   41.4            
Beginning balance at Jun. 30, 2022 (71.0) $ 0.0 0.5 (59.8) (11.7) (71.0) 0.0 0.0
Increase (Decrease) in Stockholders' Equity                
Equity-based compensation 0.4   0.4     0.4    
Foreign currency translation adjustment (2.5)       (2.5) (2.5)    
Amortization related to derivatives securities, net of tax 0.6       0.6 0.6    
Dividends (0.4)     (0.4)   (0.4)    
Net income 17.8     17.8   17.8    
Ending balance (in shares) at Sep. 30, 2022   41.4            
Ending balance at Sep. 30, 2022 $ (55.1) $ 0.0 $ 0.9 $ (42.4) $ (13.6) $ (55.1) $ 0.0 $ 0.0